$AIP

JANAC K CHARLES sold $8.2M of AIP (indirect holdings)

JANAC K CHARLES (President and CEO) sold 181,338 indirectly-held shares of Arteris, Inc. (AIP) at an average of $45.46 ($44.06–$47.08, $8.24M total) across 4 trades on 2026-07-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · JANAC K CHARLES
Published Jul 2, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 7:24 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AIP
Neutral
medium confidence
Mentioned
$AIP
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AIPNeutralLow
01

Why it matters

The newest disclosed fact is the $8.24M open-market sale of 181,338 shares (indirect holdings) on 2026-07-01 under a pre-arranged 10b5-1 plan, filed on 2026-07-02.

02

Market read

Traders may briefly reassess sentiment around AIP due to insider selling, but the 10b5-1 structure makes it less likely to drive a durable repricing without additional fundamentals.

03

What to watch

Indirect holdings and multiple trades on the same date can make the sale look more dramatic than the underlying economic intent; without accompanying company news, the trading edge is limited.

Relevance 5/10Novelty 3/10Timing: filed 2026-07-02, transaction dated 2026-07-01

Background

The article is an SEC Form 4 insider transaction disclosure for Arteris, Inc. (AIP) by its President and CEO, Janac K Charles.

Company-level read

Ticker impact

$AIPNeutralMedium confidence
Context

Arteris CEO Janac K Charles sold $8.24M of AIP shares via a 10b5-1 plan, with 181,338 shares sold at $44.06 to $47.08.

Expected impact

Likely limited, short-lived sentiment impact; watch for follow-through only if other news emerges.

Evidence & confidence

The filing is a Form 4 insider transaction with an explicit pre-arranged 10b5-1 plan, which typically reduces interpretive signal versus discretionary selling.

Market effects

No direct sector read-through; this is company-specific insider activity.

None indicated.

None indicated.

Counterpoint

Because the sale is under a 10b5-1 plan, it may reflect scheduled liquidity needs rather than bearish expectations, so traders may overreact if they treat it as a signal.

Key entities

  • Arteris, Inc.

    Company whose CEO filed the Form 4 insider sale disclosure.

  • JANAC K CHARLES

    President and CEO, reported open-market sale under a 10b5-1 plan.

Related articles

MedAI 8/10

Arteris Inc. raises FY26 sales guidance to $95-98M range

Arteris Inc. raised its FY2026 revenue guidance to $95.0 million to $98.0 million, up from $91.0 million to $95.0 million previously. The new range is above the $94.578 million analyst consensus estimate, reflecting stronger-than-expected demand for its NoC interconnects and design automation tools, according to the company.

$AIPHighAI 9/10

Arteris, Inc. (AIP): Results of Operations and Financial Condition

Arteris, Inc. (AIP) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exhibit991q2fy268-k.htm EX-99.1 Document Arteris Announces Financial Results for the Second Quarter and Estimated Third Quarter and Updated Full Year 2026 Guidance CAMPBELL, Calif. - August 6, 2026 - Arteris, Inc. (Nasdaq: AIP), a leading provider of semiconductor techn